Covid-19: Sinovac booster dose can activate cellular immunity against Omicron variant, study suggests


KUALA LUMPUR: Preliminary results of a study conducted by the Pontifical Catholic University in Chile (UC) shows that the Covid-19 Sinovac vaccine booster dose could activate cellular immunity against the Omicron variant on subjects who were given two doses of the same vaccine previously.

The objective of the study led by Millennium Institute on Immunology and Immunotherapy director Prof Dr Alexis M. Kalergis, was to assess whether the immunity activated by the Sinovac vaccine booster dose was able to recognise the Omicron variant.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

Group frees 670 river terrapins
Stopover rights for Asean airlines
Malaysian teens wow Queen Camilla
Two more airports achieve carbon certification
Connectivity will boost trade within Asean, says Loke
Penang tables RM940mil budget with lowest deficit to date
Union nursing concern over shifts
MOH to boost cardiothoracic care across the country
Lukewarm love for electric bikes
Wee: Overwhelming burden on already stressed nurses

Others Also Read